BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report) crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $1.65 and traded as high as $1.70. BioRestorative Therapies shares last traded at $1.56, with a volume of 120,765 shares traded.
BioRestorative Therapies Stock Up 2.0 %
The company has a market capitalization of $10.80 million, a PE ratio of -0.76 and a beta of 63.02. The firm’s 50 day simple moving average is $1.64 and its 200 day simple moving average is $1.58.
BioRestorative Therapies (OTCMKTS:BRTX – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.50) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.56) by $0.06. BioRestorative Therapies had a negative return on equity of 120.47% and a negative net margin of 13,728.83%. The company had revenue of $0.09 million during the quarter, compared to the consensus estimate of $0.03 million. As a group, sell-side analysts predict that BioRestorative Therapies, Inc. will post -3.52 EPS for the current fiscal year.
About BioRestorative Therapies
BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.
See Also
- Five stocks we like better than BioRestorative Therapies
- The Risks of Owning Bonds
- Battle of the Retailers: Who Comes Out on Top?
- Using the MarketBeat Stock Split Calculator
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- What Investors Need to Know About Upcoming IPOs
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.